Sarah Maenhout
- Co-authors
- Kris ThielemansJoeri L. AertsKarine BreckpotSandra Van LintCarlo HeirmanStephanie Du FourSven de MeyWout de Mey
- Topics
- Immunotherapy and Immune Responses (6 papers)Immune cells in cancer (5 papers)Cancer Immunotherapy and Biomarkers (4 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- BelgiumLuxembourgSpain
In The Last Decade
Sarah Maenhout
13 papers receiving 878 citations
Peers
Comparison fields: 5 of 63
- Immunology 552
- Oncology 425
- Molecular Biology 395
- Pulmonary and Respiratory Medicine 121
- Genetics 98
Countries citing papers authored by Sarah Maenhout
This map shows the geographic impact of Sarah Maenhout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Maenhout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Maenhout more than expected).
Fields of papers citing papers by Sarah Maenhout
This network shows the impact of papers produced by Sarah Maenhout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Maenhout. The network helps show where Sarah Maenhout may publish in the future.
Co-authorship network of co-authors of Sarah Maenhout
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Maenhout. A scholar is included among the top collaborators of Sarah Maenhout based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Maenhout. Sarah Maenhout is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 187 | |
| 2 | 101 | |
| 3 | 37 | |
| 4 | Combined VEGFR and CTLA-4 blockade increases the antigen-presenting function of intratumoral DCs and reduces the suppressive capacity of intratumoral MDSCs. | 64 |
| 5 | 63 | |
| 6 | 65 | |
| 7 | 14 | |
| 8 | 55 | |
| 9 | 34 | |
| 10 | 25 | |
| 11 | 46 | |
| 12 | 26 | |
| 13 | 172 |
About Sarah Maenhout
Sarah Maenhout is a scholar working on Immunology, Biotechnology and Oncology, having authored 13 papers that have together received 889 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Immune cells in cancer (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Immunology (552 citations), Oncology (425 citations) and Cancer Research (89 citations). Sarah Maenhout has collaborated with scholars based in Belgium, Luxembourg and Spain. Frequent co-authors include Kris Thielemans, Joeri L. Aerts, Karine Breckpot, Sandra Van Lint, Carlo Heirman, Stephanie Du Four, Sven de Mey, Wout de Mey, Hanne Locy and Mark De Ridder. Their work appears in journals such as The Journal of Immunology, Cancer Research and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.